Sun Pharmaceutical Industries Ltd. closed 14.55% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Sun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, ...

Sun Pharma plans a $100 million investment to commercialize innovative products, including Unloxcyt and Leqselvi, aiming for ...

CHENNAI: India’s largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint ...

Sun Pharma to invest $100 million in speciality products, targeting growth in innovative treatments for the future.

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India's largest listed pharma company, ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the successful completion of its acquisition of Checkpoint ...

Sun Pharmaceutical Industries Ltd. closed 14.38% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Analysts believe that recent product launches in India will further solidify Sun Pharmas leading position in the branded ...

Sun Pharma posted an 8.1% revenue rise in Q4, but profit fell 19%. EBITDA margins expanded sharply, and the company announced ...

Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger adjusted quarterly profit on Thursday, driven by ...